Market Share of Asia-Pacific Diabetes Care Drugs Industry
The Asia-Pacific diabetes care drug market is fragmented, with a few key manufacturers gaining a presence in major countries while the remaining market comprises other local or region-specific manufacturers. Mergers and acquisitions that happened between players in the recent past helped companies strengthen their market presence as well as drive innovation.
Asia-Pacific Diabetes Care Drugs Market Leaders
Astrazeneca
Boehringer Ingelheim
Novo Nordisk A/S
Eli Lilly and Company
Sanofi Aventis
*Disclaimer: Major Players sorted in no particular order
